Results 141 to 150 of about 1,636 (159)
Some of the next articles are maybe not open access.

Use of a Keratolytic Agent With Occlusion for Topical Treatment of Hyperkeratotic Seborrheic Keratoses

SKINmed: Dermatology for the Clinician, 2008
Background . Seborrheic keratoses are the most common benign tumors in adults. Despite their negative cosmetic appearance, no topical treatment is commonly recommended for these lesions. Objective . Our objective was to assess whether clinical benefit could be achieved by using a keratolytic topical agent ...
Craig G, Burkhart, Craig N, Burkhart
openaire   +2 more sources

Effect of Metamorphed Keratolytic Agent on the Behavior of Imiquimod Loaded Hybrid Vesicles Containing Gel

Journal of Pharmaceutical Sciences, 2019
The cost, side effects, and patient compliance-related issues of topically effective imiquimod have prevented its widespread acceptance. The present work intends to evaluate the feasibility of overcoming the shortcomings of poorly soluble and skin-penetrating immunomodulator by using biocompatible keratolytic agent with drug-loaded hybrid vesicles ...
Mandeep, Sharma   +4 more
openaire   +2 more sources

Development and In-vitro Characterization of Fish Oil Oleogels Containing Benzoyl Peroxide and Salicylic Acid as Keratolytic Agents

Drug Research, 2013
Topical keratolytic agents such as benzoyl peroxide (BP) and salicylic acid (SA) are one of the common treatments for inflammatory skin diseases. However, the amount of drug delivery through the skin is limited due to the stratum corneum. The purposes of this study were to investigate the ability of fish oil to act as penetration enhancer for topical ...
K, Rehman, C M, Tan, M H, Zulfakar
openaire   +2 more sources

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5.

Journal of Clinical Oncology, 2010
9017 Background: HFS is a dose-limiting toxicity of capecitabine, occurring in 43-71% of patients. No effective preventative treatment has been definitively demonstrated.
S. L. Wolf   +9 more
openaire   +1 more source

Exclusion of CTSB and FDFT1 as positional and functional candidate genes for keratolytic winter erythema (KWE)

Journal of Dermatological Science, 2012
Shaun Aron   +2 more
exaly  

Therapy With Keratolytic Gel and Corticosteroid Ointment

Archives of Dermatology, 1975
Howard P Baden
exaly  

Home - About - Disclaimer - Privacy